Ontology highlight
ABSTRACT:
SUBMITTER: Turner EM
PROVIDER: S-EPMC3285107 | biostudies-literature | 2012 Feb
REPOSITORIES: biostudies-literature
Turner Emma M EM Blazer Levi L LL Neubig Richard R RR Husbands Stephen M SM
ACS medicinal chemistry letters 20120201 2
Recently regulators of G protein signalling (RGS) proteins have emerged as potential therapeutic targets since they provide an alternative method of modulating the activity of GPCRs, the target of so many drugs. Inhibitors of RGS proteins must block a protein-protein interaction (RGS-Gα), but also be cell and, depending on the therapeutic target, blood brain barrier permeable. A lead compound (1a) was identified as an inhibitor of RGS4 in a screening assay and this has now been optimised for act ...[more]